FDA grants BTD for Venclexta in combination with azacitidine to treat patients with myelodysplastic… EP News Bureau Jul 21, 2021 Every year, approximately 10,000 people are diagnosed with myelodysplastic syndromes (MDS) in the US, and there remains a high…
